METTL3

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMETTL3
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionRNA modulators
TargetsRibonucleic Acid
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIpsen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIpsenAccenture
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A